Kerri Mowen
Gründer bei Padlock Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Gilman | M | 69 |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 Jahre |
| Todd A. Huffman | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 Jahre |
| David Grainger | M | 58 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
| Roel Bulthuis | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 Jahre |
| Michael Gladstone | M | 37 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
| Marian Nakada | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
| Paul Thompson | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
| Rab Prinjha | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Faat Ting Cheng | M | 56 |
Southern Illinois University
| 6 Jahre |
| Muhammad Khilji | M | 58 |
Southern Illinois University
| 6 Jahre |
| Sarah Gabriel | F | - |
Southern Illinois University
| 4 Jahre |
| Craig D. Nelson | M | 70 |
Southern Illinois University
| 4 Jahre |
| Andrew White | M | - |
Southern Illinois University
| 2 Jahre |
| April Pica | F | - |
Southern Illinois University
| 4 Jahre |
| Amanda Black | F | 48 |
Southern Illinois University
| 4 Jahre |
| Janet Torrisi-Mokwa | F | - |
Southern Illinois University
| 5 Jahre |
| Mohammed Saud Abdul Aziz Al-Badr | M | 65 |
Southern Illinois University
| 3 Jahre |
| Christopher Hartman | M | 54 |
Southern Illinois University
| 4 Jahre |
| Jerry L. Greene | M | - |
Southern Illinois University
| 4 Jahre |
| Teresa Katubig | F | - |
Southern Illinois University
| 4 Jahre |
| Steve Cotone | M | - |
Southern Illinois University
| 4 Jahre |
| Rajesh Devraj | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 1 Jahre |
| Daniel Furey | M | - |
Southern Illinois University
| 4 Jahre |
| Abdul Rahman Al-Ismail | M | - |
Southern Illinois University
| 1 Jahre |
| Ufuk Ince | M | - |
Southern Illinois University
| - |
| Lilia Mavrikova | F | - |
Southern Illinois University
| 2 Jahre |
| Mariana Nacht | M | 60 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 2 Jahre |
| Mehmet Ali Cer | M | - |
Southern Illinois University
| 3 Jahre |
| Hsing-Yen Tsai | M | 59 |
Southern Illinois University
| 1 Jahre |
| Ivo Vassilev Ivanov | M | - |
Southern Illinois University
| 1 Jahre |
| Shuo-Wei Shih | M | 55 |
Southern Illinois University
| 4 Jahre |
| Siu Fung Chiu | F | 55 |
Southern Illinois University
| 2 Jahre |
| William Mirecki | M | 53 |
Southern Illinois University
| 4 Jahre |
| Matthew Warrens | M | - |
Southern Illinois University
| 4 Jahre |
| Jeff Vivacqua | M | - |
Southern Illinois University
| 5 Jahre |
| James McCormick | M | 57 |
Southern Illinois University
| 2 Jahre |
| Walid Abanumay | M | 57 |
Southern Illinois University
| 3 Jahre |
| Sean Loving | M | - |
Southern Illinois University
| 4 Jahre |
| Terry Hart | M | 55 |
Southern Illinois University
| 5 Jahre |
| James Eric Mineman | M | - |
Southern Illinois University
| 5 Jahre |
| Lisa Ann Teter | F | - |
Southern Illinois University
| 5 Jahre |
| Troy Ward | M | - |
Southern Illinois University
| 4 Jahre |
| Kailash Birmiwal | M | - |
Southern Illinois University
| 7 Jahre |
| Scott Thoma | M | - |
Southern Illinois University
| 4 Jahre |
| Eric Sites | M | 45 |
Southern Illinois University
| 4 Jahre |
| Adelene Perkins | F | 54 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
| Teri Lesicko | F | - |
Southern Illinois University
| 2 Jahre |
| John Henkhaus | M | - |
Southern Illinois University
| 4 Jahre |
| Robert Hess | M | - |
Southern Illinois University
| 2 Jahre |
| Eryn Lampe | F | - |
Southern Illinois University
| 3 Jahre |
| John Theodore Sanders | M | 82 |
Southern Illinois University
| 5 Jahre |
| Ken M. Loveless | M | - |
Southern Illinois University
| 4 Jahre |
| Don W. Adams | M | - |
Southern Illinois University
| 4 Jahre |
| Richard Marincic | M | - |
Southern Illinois University
| 4 Jahre |
| Kelly M. Malson | F | 53 |
Southern Illinois University
| 4 Jahre |
| Xiao Yang Yu | M | 70 |
Southern Illinois University
| 2 Jahre |
| Tim Vediz | M | - |
Southern Illinois University
| 4 Jahre |
| Christopher K. Davies | M | 66 |
Southern Illinois University
| 4 Jahre |
| Yun Fei Chen | M | 52 |
Southern Illinois University
| 3 Jahre |
| Robert Berry | M | - |
Southern Illinois University
| 3 Jahre |
| Jian Wen Liao | M | 57 |
Southern Illinois University
| 3 Jahre |
| Shelton Frey | M | - |
Southern Illinois University
| 3 Jahre |
| Raghu Iyer | M | - |
Southern Illinois University
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 63 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kerri Mowen
- Persönliches Netzwerk